Here’s the latest on meningococcus, based on recent public health updates.
United Kingdom outbreak in Kent (early 2026): The UK Health Security Agency reported an outbreak of meningococcal disease in Kent with several dozen confirmed cases and a couple of deaths as of March 2026. Early genetic analysis identified a group B meningococcus strain, and vaccination with the MenB vaccine (Bexsero) is being used as part of the response. Vaccination and antibiotic treatments have been actively offered to at-risk groups, including students living in halls and contacts of cases.[3]
U.S. situation (2024–2025): The CDC and JAMA reported surges in meningococcal disease in the U.S. around 2024, including a notable rise in cases and a higher proportion caused by specific sequence types; public health agencies emphasized vaccination and surveillance as key strategies. By 2024–2025, U.S. disease activity had drawn heightened attention from clinicians and public health authorities due to increases in invasive meningococcal disease, though long-term trends have varied by region and strain.[2][4][9]
Surveillance and vaccination context: In the United States, meningococcal disease is tracked through national surveillance, with 2024 data indicating one of the highest annual case counts in years, prompting ongoing vaccination discussions—particularly around MenACWY and MenB vaccines and future pentavalent vaccine considerations. Public health guidance continues to stress vaccination, rapid diagnosis, and post-exposure prophylaxis for close contacts.[1][4]
France and Europe: Santé publique France and other European health authorities maintain ongoing surveillance of invasive meningococcal infections, reiterating the importance of timely reporting and vaccination where appropriate. Public health updates emphasize that MenB vaccination can offer protection against circulating strains in certain settings.[8]
Public health messaging: Health organizations have issued alerts and guidance to clinicians and the public to recognize meningococcal disease symptoms promptly (sudden fever, severe headache, stiff neck, nausea, vomiting, rash) and to seek urgent care. They also highlight that vaccination remains a critical preventive tool, with recommendations varying by age, risk group, and local outbreak status.[6][9]
Illustration: If you’d like, I can generate a brief one-page summary chart showing recent US vs UK meningococcal disease activity by year and vaccine coverage, which could help you compare trends at a glance.
Would you like me to tailor this to specific regions near Los Angeles or provide guidance on meningococcal vaccination for different age groups? I can also pull the most current local advisories if needed.
Sources: UK Kent outbreak updates and vaccination response; US surveillance and CDC notices on rising meningococcal disease; European France public health surveillance; ongoing vaccination guidance from national health agencies.[4][2][3][6][8]
Invasive meningococcal infections are serious illnesses and must be reported immediately to the Regional Health Agencies (ARS). Epidemiological surveillance is conducted by Santé publique France.
www.santepubliquefrance.frThere has been an increase of invasive meningococcal disease cases in the US, according to a health news alert issued by the CDC.
www.healthline.comMeningococcus group B, the most prevalent strain of meningococcal infection, is prevented with 79 per cent effectiveness in children and young adults inoculated with the 4CMenB vaccine, also known as Bexsero, according to a new collaborative study from researchers in Portugal and the UK and led by the University of Bristol which evaluated the vaccine’s […]
meningitis.com.auThe characteristics, diagnosis, management, surveillance and epidemiology of meningococcal disease.
www.gov.ukLatest updates from the ongoing outbreak.
www.gov.ukUpdates on respiratory illness and vaccine-preventable diseases
www.cdc.govFind out about a meningococcal outbreak in the UK and about U.S. vaccination approaches for this infection. The UK Health Security Agency (UKHSA) is investigating an outbreak of meningococcal disease in Kent. As of March 25, 2026, the outbreak consisted of 20 confirmed laboratory cases, including two deaths. Two total notifications were under review. Early genetic analyses have identified group B meningococcus as the source of the outbreak. Importantly, the MenB vaccine, Bexsero, is...
www.chop.eduThe Centers for Disease Control has issued an alert warning for the public and healthcare providers to look out for meningococcal disease. The new strain has resulted in 143 cases since the start of…
people.comAs of late March 2024, health officials in the US have recorded 143 cases of meningococcal disease, 101 of them caused by a strain of the bacteria Neisseria meningitidis known as sequence type (ST) 1466. The total number of cases of the disease represents a more than 75% increase over those reported...
jamanetwork.comCDC tracks meningococcal disease cases nationally. U.S. disease rates are at historic lows.
www.cdc.gov